David Martin - Guardian Pharmacy Vice Officer
| GRDN Stock | 21.63 0.27 1.23% |
Executive
David Martin is Vice Officer of Guardian Pharmacy Services,
| Address | 300 Galleria Parkway SE, Atlanta, GA, United States, 30339 |
| Phone | 404 810 0089 |
| Web | https://guardianpharmacy.com |
David Martin Latest Insider Activity
Tracking and analyzing the buying and selling activities of David Martin against Guardian Pharmacy stock is an integral part of due diligence when investing in Guardian Pharmacy. David Martin insider activity provides valuable insight into whether Guardian Pharmacy is net buyers or sellers over its current business cycle. Note, Guardian Pharmacy insiders must abide by specific rules, including filing SEC forms every time they buy or sell Guardian Pharmacy'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
David Martin over two weeks ago Disposition of 5640 shares by David Martin of Titan International at 12. subject to Rule 16b-3 | ||
David Martin over three months ago Disposition of 2216 shares by David Martin of FG Annuities at 48.33 subject to Rule 16b-3 |
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| MD MBA | Molecular Partners AG | 59 | |
| Susan Anderson | Uber Technologies | N/A | |
| Steve Kerdock | Arrow Electronics | N/A | |
| Patrick McKillop | Asure Software | N/A | |
| Steven Madden | Steven Madden | 68 | |
| Alaxandar Wang | Uber Technologies | N/A | |
| Adam CBE | Pearson PLC ADR | 60 | |
| Karla Frieders | Steven Madden | 48 | |
| Ginny Ziegler | Pearson PLC ADR | N/A | |
| Dave Treat | Pearson PLC ADR | N/A | |
| Prashanth MahendraRajah | Uber Technologies | 55 | |
| Jennifer MBA | Uber Technologies | 54 | |
| Renate Gloggner | Molecular Partners AG | 55 | |
| Yasmine Rodriguez | Asure Software | N/A | |
| Daniel Steiner | Molecular Partners AG | N/A | |
| Bjarne Tellmann | Pearson PLC ADR | N/A | |
| Albert Hitchcock | Pearson PLC ADR | 60 | |
| Pamela Trail | Molecular Partners AG | 69 | |
| Mike Vannoy | Asure Software | N/A | |
| Ruby Zefo | Uber Technologies | N/A | |
| Anna Persson | Pearson PLC ADR | 50 | |
Guardian Pharmacy Leadership Team
Elected by the shareholders, the Guardian Pharmacy's board of directors comprises two types of representatives: Guardian Pharmacy inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Guardian. The board's role is to monitor Guardian Pharmacy's management team and ensure that shareholders' interests are well served. Guardian Pharmacy's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Guardian Pharmacy's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Douglas Towns, VP Counsel | ||
| Brian Rosati, President Daytona | ||
| David Martin, Vice Officer | ||
| Rockford Anderson, President Iowa | ||
| Bethany RPh, Senior Marketing | ||
| Robin Smith, President Services | ||
| Kendall RPh, Executive Operations | ||
| Fred Burke, President CEO | ||
| Vicki Crabtree, Vice Resources | ||
| David Morris, Executive CFO |
Guardian Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Guardian Pharmacy a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Profit Margin | (0.07) % | ||||
| Operating Margin | (0.33) % | ||||
| Current Valuation | 1.29 B | ||||
| Shares Outstanding | 9.2 M | ||||
| Shares Owned By Insiders | 0.96 % | ||||
| Shares Owned By Institutions | 99.04 % | ||||
| Number Of Shares Shorted | 753.91 K | ||||
| Price To Book | 9.80 X | ||||
| Price To Sales | 1.07 X | ||||
| Revenue | 1.05 B |
Pair Trading with Guardian Pharmacy
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Guardian Pharmacy position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Guardian Pharmacy will appreciate offsetting losses from the drop in the long position's value.Moving together with Guardian Stock
| 0.72 | AMS | American Shared Hospital Earnings Call This Week | PairCorr |
Moving against Guardian Stock
| 0.44 | BKD | Brookdale Senior Living | PairCorr |
| 0.35 | CHE | Chemed Corp | PairCorr |
| 0.35 | RHE-PA | Regional Health Prop | PairCorr |
| 0.31 | AGL | agilon health | PairCorr |
The ability to find closely correlated positions to Guardian Pharmacy could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Guardian Pharmacy when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Guardian Pharmacy - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Guardian Pharmacy Services, to buy it.
The correlation of Guardian Pharmacy is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Guardian Pharmacy moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Guardian Pharmacy moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Guardian Pharmacy can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Guardian Pharmacy Services,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Retail space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardian Pharmacy. If investors know Guardian will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardian Pharmacy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.38) | Revenue Per Share 18.499 | Quarterly Revenue Growth 0.197 |
The market value of Guardian Pharmacy is measured differently than its book value, which is the value of Guardian that is recorded on the company's balance sheet. Investors also form their own opinion of Guardian Pharmacy's value that differs from its market value or its book value, called intrinsic value, which is Guardian Pharmacy's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardian Pharmacy's market value can be influenced by many factors that don't directly affect Guardian Pharmacy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardian Pharmacy's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardian Pharmacy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardian Pharmacy's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.